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1  | INTRODUC TION
The first successful xenograft implantation of a chemically treated pig 
heart valve into a human was carried out more than 50 years ago, and 
pigs are now a major source of these bioprosthetics.1,2 Similarly, xeno-
transplantation of porcine Langerhans islet cells to diabetic humans was 
first attempted in 1994, and efforts to make this an effective therapy 
are ongoing.3,4 Owing to these precedents, pigs are considered the pre-
ferred donor species for xenotransplantation to humans, with recent 
promising trials of successful porcine kidney and heart xenotransplanta-
tion to nonhuman primates.5,6 Particularly, pigs are inexpensive, easy to 
breed in a controlled environment with large litter sizes, and the organ 
size of pigs is comparable to that of humans. However, immunological 
rejection of xenograft from pigs has been a major issue in the past.6,7
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Abstract
Routine large- scale xenotransplantation from pigs to humans is getting closer to clini-
cal reality owing to several state- of- the- art technologies, especially the ability to rap-
idly engineer genetically defined pigs. However, using pig organs in humans poses 
risks including unwanted cross- species transfer of viruses and adaption of these pig 
viruses to the human organ recipient. Recent developments in the field of virology, 
including the advent of metagenomic techniques to characterize entire viromes, have 
led	to	the	identification	of	a	plethora	of	viruses	in	many	niches.	Single-	stranded	DNA	
(ssDNA)	 viruses	 are	 the	 largest	 group	 prevalent	 in	 virome	 studies	 in	 mammals.	
Specifically,	the	ssDNA	viral	genomes	are	characterized	by	a	high	rate	of	nucleotide	
substitution, which confers a proclivity to adapt to new hosts and cross- species bar-
riers.	Pig-	associated	ssDNA	viruses	 include	torque	teno	sus	viruses	(TTSuV)	 in	the	
Anelloviridae family, porcine parvoviruses (PPV), and porcine bocaviruses (PBoV) 
both in the family of Parvoviridae, and porcine circoviruses (PCV) in the Circoviridae 
family, some of which have been confirmed to be pathogenic to pigs. The risks of 
these viruses for the human recipient during xenotransplantation procedures are 
relatively unknown. Based on the scant knowledge available on the prevalence, pre-
dilection,	and	pathogenicity	of	pig-	associated	ssDNA	viruses,	careful	screening	and	
monitoring are required. In the case of positive identification, risk assessments and 
strategies to eliminate these viruses in xenotransplantation pig stock may be needed.
K E Y W O R D S
cross-species, porcine circovirus (PCV), porcine parvovirus (PPV), torque teno sus virus 
(TTSuV), xenotransplantation, zoonotic
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Developments in genome editing technology, such as the wide 
availability of the CRISPR- Cas9 system, have opened avenues to 
engineer the pig genome and create immunologically safe organ 
donors for humans in the near future.8	Apart	from	the	compatibil-
ity and immunological rejection of the xenotransplant, microbial 
safety is also a primary concern in xenotransplantation. Pigs are a 
relatively distant species to humans compared to nonhuman pri-
mates, and overall, there is a perceived lower risk of cross- species 
pathogen transmission. However, pigs are known to be a reservoir 
of	viruses	that	are	pathogenic	to	humans	such	as	Japanese	enceph-
alitis	virus,	Nipah	virus,	swine	influenza	A	virus,	Menangle	virus,	and	
Hepatitis E virus.9-14 In addition to these viruses, porcine cytomega-
lovirus and vesicular stomatitis virus are also known to have zoonotic 
potential.15,16
Cross- species transmissions of viruses between pigs and humans 
can be broadly described to occur under three scenarios. The first 
“classical scenario” is facilitated by shared ecosystems of humans 
and pigs and a certain degree of susceptibility of humans to these 
viruses.9,12 This scenario includes exposure of humans to pig viruses 
via the food chain, farming, and veterinary activities. In the second 
scenario, humans are exposed to pig viruses without being in the 
proximity of pigs, through products of pig origin used in pharma-
ceutical products for human patients. These products may include 
anticoagulants, respiratory agents, and digestive supplements that 
contain or are based on pork by- products. In addition, human vac-
cines may be prepared on porcine cell lines or use porcine- derived 
cell	 culture	 supplements.	 Administration	 of	 these	 can	 lead	 to	 un-
intended exposure of humans with pig virus contaminants such as 
the well- documented case of porcine circovirus 1 (PCV1) in live- 
attenuated rotavirus vaccines.17
However, xenotransplantation poses an altogether different 
third scenario where tissues or organs from pigs are placed directly 
inside the body of the human recipient, who is likely under immuno-
suppressive treatment. Viruses that are being passaged with the xe-
notransplant may continue to replicate in the xenografted organ and 
could replicate in the host as well. Therefore, the risk of exposure 
to viruses from donor pigs to the xenotransplant recipient is rather 
unique. Such viral contaminants may result in active infections of 
host tissues and can contribute to problems in the engraftment of 
the transplanted tissue such as inflammation and adverse immune 
reactions.
2  | PIG SELEC TION FOR 
XENOTR ANSPL ANTATION
There is a wide availability of diagnostic reagents and well- 
established monitoring programs for selected pathogens im-
portant to commercial pig production. In contrast, pigs bred 
and maintained for xenotransplantation under high biosecurity 
procedures require a different approach to ensure inadvertent 
transmission	of	porcine	viruses	to	the	recipient.	A	real	concern	in	
xenotransplanation is the presence of asymptomatic viral swine 
infections, which are not part of routine pig veterinary screen-
ing. Viruses of pigs which are of potential risk in xenotransplan-
tation have been widely researched and reviewed.15,16 Some 
of these viruses cause overt infections, others such as porcine 
lymphotropic herpesvirus 1 (PLHV- 1), PLHV- 2, and PLHV- 3 may 
cause latent infections thereby complicating any screening pro-
cesses. Yet other viruses such as porcine endogenous retrovirus 
C (PERV- C) are integrated in the genome of some pigs, which 
makes screening for them easy.16	 PERV-	A	 and	 PERV-	B,	 inte-
grated in the genome of all pigs and human- tropic, may infre-
quently produce infective particles and can infect human cells as 
well as cells of other species. On the other hand, the pig- tropic 
and infective PERV- C, which is not found in all pigs, can recom-
bine	with	chromosome	integrated	PERV-	A	and	produce	infective	
viruses.18	 PERV-	A/C	 recombinants	 are	 also	 human-	tropic,	 but	
their replication rate is much higher compared to the parental 
strains.18,19 They are absent in the germline, but integrate de 
novo in cells of different organs.19,20 Differences in the chro-
mosomal copy number of PERV in different organs in an indi-
vidual pig indicate that these viruses are still active, replicate 
to produce infectious particles, and can infect and integrate de 
novo at other sites.18,20 For PERV specifically, advances in ge-
nome engineering techniques have led to the generation of cell 
lines in which all genomic PERV material has been disrupted, and 
these cells have been used to produce transgenic pigs by somatic 
cell nuclear transfer.8,21 This comprises a major achievement in 
overcoming the previous obstacle of genomic integrated PERVs 
in xenotransplantation. However, re- infection of such PERV dis-
rupted	 pigs	 with	 PERV-	C	 or	 recombinant	 PERV-	A/C	 remains	 a	
risk. In the case of other infectious viruses with no obvious ef-
fect on pig health or production parameters, a mixed strategy 
for screening could be used. Protocols for genome detection by 
PCR and antibody detection by serological assays of pig popu-
lations and individual pigs intended for transplantation should 
be devised to prevent cross- species virus transmission during 
transplantation.
3  | SINGLE- STR ANDED DNA VIRUSES IN 
PIGS
In	 this	 review,	 ssDNA	 genome	 viruses	 in	 the	 context	 of	
xenotransplantation are being discussed. Under the Baltimore 
virus	 classification	 system,	 ssDNA	 viruses	 are	 classified	 as	
Group II viruses.22,23	 ssDNA	 viruses	 are	 not	 enveloped,	 very	
resistant to inactivation, can be found in a variety of verte-
brate and invertebrate hosts, and have a high mutation rate 
approaching	 that	 of	 RNA	 viruses.22 The three major families 
of	 ssDNA	viruses	 of	 potential	 importance	 in	 xenotransplanta-
tion using pig- derived organs are Anelloviridae, Circoviridae, and 
Parvoviridae (Table 1).
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3.1 | Anellovirus
3.1.1 | Epidemiology in humans and pigs
The members of the Anelloviridae have closed circular genomes and 
typically encode four genes, including a replicase gene which is es-
sential for virus replication.24	Anelloviruses	 are	 estimated	 to	have	
a mutation rate of 10-4 nucleotide substitutions per site per year.25 
The first member of this family, torque teno virus (TTV), was isolated 
in a human case of post- transfusion hepatitis.26 This virus is now 
known to be ubiquitous in the human population worldwide, and in 
one instance has been identified in 94% of analyzed healthy indi-
viduals.27 Five major phylogenetic clusters of TTV differing mainly in 
the ORF1 (replicase gene) are observed.28	Although	the	TTV	has	not	
been definitively associated with any disease, it is known to suppress 
the host interferon response.28 TTV can replicate to high levels, 
with an increase in TTV levels being observed in conditions asso-
ciated with immunosuppression such as human immunodeficiency 
virus (HIV) infection, untreated solid cancers, and stem cell or solid 
organ transplantation.28,29 The TTV level is inversely correlated with 
CD8+57+ T lymphocytes and is thought to be indicative of the status 
of immunocompetence in humans.28,30	A	high	TTV	level	is	correlated	
with nonrejection of transplants in allografts.28,31	After	the	discov-
ery of TTV, other members of the Anelloviridae such as Torque Teno 
mini virus (2000) and Torque Teno midi virus (2007) have been iden-
tified in human and nonhuman primate populations.28,32,33 It is now 
estimated that Anelloviridae constitute around 68% of the virome in 
healthy humans, making this virus group the largest component.28
The Torque teno sus virus (TTSuV) was first discovered in 2002 
from	healthy	pig	serum	in	Japan.34 It is now known that TTSuVs are 
prevalent worldwide and two distinct genera, TTSuV1 and TTSuV2 
with 40- 50% sequence identity, have been identified (Table 1). 
TTSuV1 and TTSuV2 are both further subclassified into two geno-
types.35-37	Antigenic	cross-	reactivity	 is	observed	between	the	two	
genotypes TTSuV1a and TTSuV1b but not between the two species 
TTSuV1a/b and TTSuV2.35	 Although	 varying	 levels	 of	 prevalence	
of TTSuVs in farmed pigs are reported, prevalence rates generally 
increase with age and may reach up to 100% in finisher and breed-
ing pigs.37-39 In addition, natural mixed infections of TTSuV1 and 
TTSuV2 have been observed.38 TTSuVs are transmitted by the oral- 
fecal and vertical routes, with the former considered the main route 
of transmission.38,40 TTSuV is also found in boar semen used for ar-
tificial insemination, but the importance of this virus transmission 
route is unknown.41
3.1.2 | Infection in pigs and tropism
Experimental infections of TTSuV1 and TTSuV2 of gnotobiotic pigs 
suggest a pathogenic potential of these viruses; however, conclusive 
evidence of the pathogenicity of TTSuVs in pigs is not established to 
date.36,42	Although	a	positive	correlation	between	the	TTSuV	DNA	
levels and the major pig pathogen porcine circovirus type 2 (PCV2) 
has been observed in clinically affected pigs, this is interpreted to be 
an effect of immunosuppression caused by high levels of PCV2.43 
TTSuV1 and TTSuV2 are distributed in many organs of naturally 
infected pigs, with highest virus concentration in bone marrow. 
Moreover, T lymphocytes seem to carry a high TTSuV genome 
load.43-46 In farmed pigs, organs of potential value in transplanta-
tion such as kidney or liver are found to harbor TTSuV1 and TTSuV2 
with a prevalence of more than 50%.43,45,46 Islet cells in the pan-
creas could contain TTSuV acquired through circulation; however, 
this	has	not	been	examined.	In	addition,	TTSuV	DNA	was	identified	
in porcine biologicals such as Mycoplasma hyopneumoniae bacterins, 
porcine products such as trypsin, and in cell cultures derived from 
different species.47,48
3.1.3 | Zoonotic potential of TTSuV
Interestingly,	TTV	DNA	 is	 found	 in	pigs	and	TTSuV	DNA	 is	 found	
in humans.49,50 Preliminary evidence indicates TTSuV1 replication in 
human peripheral blood monocytes (PBMCs) and the presence of 
antibodies against TTSuV1 ORF2 (a nonstructural protein) in human 
serum samples suggests a zoonotic potential.50 Of note, TTSuV1- 
infected human PBMCs are shown to be impaired in their mitogenic 
response.50	 In	 addition	 to	 humans,	 TTSuV1	 DNA	 and	 antibodies	
against TTSuV1 ORF2 antibodies are found in many mammalian hosts 
such as horses, cattle, sheep, and dogs, indicative of promiscuity in 
the host range of TTSuV1.49	At	present,	cell	culture	propagation	of	
TTSuV is not established. The potential of this virus to infect human- 
origin cell lines needs to be further explored, as this may offer clues 
to	its	zoonotic	potential.	Although	the	pathogenicity	of	neither	TTV	
nor TTSuVs has been clearly established, the potential of TTSuV to 
cross the species barrier and suppress the mitogenic response of 
human PBMCs raises a concern in xenotransplantation.49,50
3.1.4 | Negative pig sources
Infections with TTSuV are thought to be widely prevalent and per-
sistent; however, fetuses can be negative for TTSuV and it appears 
feasible to derive TTSuV1 and TTSuV2 negative herds by a combi-
nation of cesarean delivery and high biosecurity conditions of rear-
ing.41 However, previous contamination of the pig housing facility 
with	Anelloviruses	may	be	an	issue	and	needs	to	be	resolved	if	exist-
ing facilities are being re- utilized rather than using new buildings for 
donor pig housing. Currently, there is no commercial vaccine avail-
able against TTSuV.
3.2 | Parvovirus
3.2.1 | Epidemiology in humans and pigs
The Parvoviridae family consists of eight genera which are char-
acterized	 by	 a	 linear	 ssDNA	 genome,	 ranging	 from	 4	 to	 6	kb	 in	
size, typically with two open reading frames and terminal repeats 
essential for replication.51 Parvoviruses infect a range of verte-
brate hosts such as humans, pigs, dogs, cats, and avian species. 
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Viruses in this group have a high mutation rate, especially in the 
capsid gene, to the order of approximately 10−4 nucleotide sub-
stitutions per site per year.52-55 This high mutation rate is thought 
to favor their rapid adaptation to new host species. Parvoviruses 
are known to have a predilection for rapidly dividing cells, such 
as bone marrow stem cells and enterocytes.51 In particular, the 
synthesis (S) phase of the cell cycle is thought to benefit their 
replication.51 Human parvovirus B19 (B19V), human bocavirus 
1-	4	(HBoV1-	4),	and	human	parvovirus	4	(PARV4)	are	some	of	the	
human viruses in the Parvoviridae family considered as pathogenic 
or a potential risk.56-58 B19V is associated with acute and chronic 
infections in healthy and immunocompromised individuals causing 
disease conditions such as erythema infectiosum, aplastic anemia, 
and arthropathy.58	Although	there	is	no	definitive	evidence,	HBoV	
is thought to be associated, at least as a coinfection, in respiratory 
tract infections in children and gastrointestinal tract infections in 
all age groups.59	Similarly,	PARV4	is	associated	with	HIV	and	hep-
atitis C virus (HCV) infections and is found in higher prevalence 
in intravenous narcotics users, but a causative link with disease 
has not been identified.58 Human parvoviruses are known to be 
intransigent to in vitro culture and only a few have been propa-
gated in cell culture such as the B19V and HBoV.60-63 In pigs, eight 
species of the Parvoviridae family classified under four genera are 
described (Table 1); ungulate protoparvovirus 1 [classical porcine 
parvovirus (PPV) or PPV1], ungulate tetraparvovirus 2 (PPV3), un-
gulate tetraparvovirus 3 (PPV2, also known as porcine hokovirus 
or	porcine	partetravirus	or	porcine	PARV4),	ungulate	copiparvovi-
rus 2 (PPV4, PPV5 and PPV6), ungulate bocaparvovirus 2 [porcine 
bocavirus (PBoV) 1, 2 and 6], ungulate bocaparvovirus 3 (PBoV 5), 
ungulate bocaparvovirus 4 (PBoV 7), and ungulate bocaparvovi-
rus 5 (PBoV 3, PBoV4.1 and PBoV4.2).64,65 PPV1 was first identi-
fied in the early 1970s in association with abortions in pigs.66-68 
However, it has also been associated with enteric disease and skin 
infections in growing pigs.69 In pigs, PPVs and PBoVs, in line with 
the corresponding viruses infecting mammals, have a high rate of 
mutation.70
3.2.2 | Infection in pigs and tropism
Other than for PPV1, pathogenicity of any of the newly identi-
fied PPVs or PBoVs has not yet been conclusively demonstrated. 
Parvovirus	DNA	can	be	detected,	even	in	healthy	pigs,	in	a	wide	range	
of pig tissues including tissues of possible interest for xenotransplan-
tation such as liver and kidney.71 The PPVs and PBoVs are considered 
possible triggers for the development of systemic disease in PCV2- 
infected pigs.72	A	survey	in	the	United	States	using	random	samples	
submitted for diagnostics from 2006 to 2013 showed the preva-
lence of PPV in tissues as follows: 15.2% for PPV1, 42.7% for PPV2, 
9.1% for PPV3, 4.3% for PPV4, and 3.0% for PPV5.71 In another 
study	conducted	in	Japan,	PPVs	were	detected	in	high	frequencies	
as coinfections in PCV2- infected pigs; PPV1 coinfection was found 
in 67% of the pigs, PPV2 in 58%, PPV3 in 39%, PPV4 in 33%, and 
PBoV7 was detected in 55% of the pigs.72 Overall, the studies show 
that PPV1 and PPV2 are the most prevalent parvoviruses in pigs.71-
73 PPV1, PBoV3, and PBoV4 are the only pig- associated Parvoviridae 
members that have been cultured in vitro.74,75
3.2.3 | Zoonotic potential of PPV
Porcine parvovirus 1 does not infect cell lines of human or primate 
origin.74 Hemophilia patients treated with porcine clotting factor 
VIII,	in	which	PPV1	DNA	was	detected,	did	not	develop	any	antibod-
ies to PPV1.76 There is no information on the ability of other PPVs to 
replicate in human cells. However, the general ability of parvoviruses 
to cross- species barrier has been well noted among virologists.77,78 
The history of emergence of canine parvovirus (CPV) from feline 
panleukopenia virus (FPV) and its further evolution into novel geno-
types with varying host range (CPV2a, b and c) is a paradigm in virol-
ogy.77,79 The evolution of CPV has been recapitulated in vitro and a 
single mutation is sufficient to allow replication in a novel host cell.77 
Similarly, the rodent H1 parvovirus is well studied for its oncolytic 
potential in human cancer cells.80,81 The ability of the H1 virus to 
selectively infect human cancer cells is thought to be determined by 
the capsid protein and enabled by the increased rate of proliferation 
of the cancerous cells and their subdued antiviral mechanisms.81,82 
In the case of oncolytic rodent H1 parvovirus, its ability to replicate 
in human cells is proof of having sufficient factors for the virus to 
replicate and produce an infective progeny H1 virus in cancerous 
cells. Given the rapid mutation rate of PPVs and the overall ability 
of parvoviruses to cross- species barriers, the risk of widely preva-
lent PPVs in a xenotransplantation setting, where the recipient will 
undergo prolonged immunosuppressive regimen, is worth closer 
scrutiny.
3.2.4 | Negative pig sources
While	vaccines	are	available	for	PPV1	and	widely	used	in	breeding	
herds, they do not prevent infection but rather protect against dis-
ease.83	As	the	PPVs	and	PBoVs	are	not	found	in	all	sows	and	piglets,	
derivation of free piglets is feasible and the chances can be improved 
by cesarean section and colostrum deprivation. However, these vi-
ruses are widespread and very resistant to disinfection; thus, con-
tamination of the pig housing facility may be difficult to resolve and 
could result in infection of piglets early in life.
3.3 | Porcine circovirus
3.3.1 | Epidemiology in humans and pigs
Porcine circoviruses (PCV) are small, icosahedral, nonenveloped 
virus	particles	with	 a	 circular	 ssDNA	genome	of	1.7-	2	kb	 size.	The	
genomes of members of the Circoviridae family are characterized 
by a stem- loop structure at the origin of replication and encode 
for replicase proteins and a single capsid protein in opposite ori-
entations in addition to other putative genes.24 These are referred 
to	 as	 circular	 rep-	encoding	 ssDNA	 (CRESS-	DNA)	 genomes.24 The 
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replicase protein consists of endonuclease and helicase motifs and 
is essential for the replication of the circoviral genome by rolling 
circle replication.22 Circoviruses have the highest rate of mutation 
among	ssDNA	viruses,	and	the	PCV2	genome	is	estimated	to	incur	
1.2 × 10−3 nucleotide substitutions per site per year.22,84	Although	
no specific circoviruses of humans have been reported, cycloviruses 
and gemycircularviruses, classified under the Cyclovirus genus of 
the Circoviridae family, have been detected in cerebrospinal fluids 
of humans.85 In pigs, three different species have been identified, 
PCV1, PCV2, and PCV3. PCV1 was discovered as a contaminant of 
the porcine kidney cell line PK- 15 in 1974 and is today considered 
nonpathogenic to pigs.86,87 In the late 1990s, PCV2 was identified as 
a major pig pathogen associated with a series of disease outbreaks 
in	North	America	and	Europe.88-90 PCV2 is an essential etiological 
agent that, along with other coinfecting pig pathogens, causes immu-
nosuppression that leads to postweaning multisystemic wasting syn-
drome	(PMWS).91 PCV3 is a more recently identified member of the 
genus identified across the world without any conclusive link to path-
ogenicity.92,93	In	a	U.S.	National	Animal	Health	Monitoring	System’s	
(NAHMS)	pig	study	conducted	in	2006,	a	total	of	6234	serum	sam-
ples were collected from farms with 100 or more pigs and these sera 
were	analyzed	for	PCV1	and	PCV2	DNA.94	While	over	82%	of	sera	
from 185 farms were positive for PCV2 by PCR, only 2.4% were posi-
tive	for	PCV1.	More	than	80%	of	PCV2	DNA-	positive	pigs	were	also	
positive for anti- PCV2 antibodies.94 Comprehensive data on preva-
lence of the novel PCV3 are yet being generated. However, similar to 
PCV1 and PCV2, it is considered to be prevalent worldwide.92
3.3.2 | Infection in pigs and tropism
Under experimental conditions, PCV1- infected pigs remain clini-
cally healthy and do not develop histopathological lesions. However, 
PCV1 antigen is detected in multiple organs and tissues and PCV1 
viremia can be detected in sera for up to 35 days postinocula-
tion.95-97 Experimental infection of pigs with PCV2 alone is simi-
lar to PCV1 infection and is almost always subclinical. However, in 
combination with other factors including infectious agents, PCV2 
infection can lead to manifestation of clinical disease in a percentage 
of infected pigs, with typical microscopic lesions of mild- to- sever 
histiocytic- to- granulomatous inflammation of multiple organs, for-
mation of multinucleated giant cells, and lymphoid depletion.96 Viral 
tissue load is generally high in clinically affected PCV2- infected pigs 
and includes organs of interest for xenotransplantation such as liver, 
kidneys, and pancreas, while in subclinically infected pigs, PCV2 
replication is often limited to individual lymph nodes. Efficacious 
vaccines against PCV2 that prevent pathogenesis and reduce PCV2 
viremia and shedding are available, but as with most vaccines, they 
do not prevent infection of pigs.98
3.3.3 | Zoonotic potential of PCV
The threat posed by PCVs during xenotransplantation has been 
previously reviewed.99 PCV1 and PCV2 are both propagated 
mainly in the porcine kidney cell line PK- 15 but can be also cultured 
in other cells of porcine origin.100-102 Under extreme in vitro condi-
tions, it has been reported that PCV1 undergoes nonproductive 
replication in human cell lines (293, HeLa, and Chang liver cells), 
in which PCV1 replication and gene expression were detected 
but infectious virus particles are not produced.102 Human blood 
leukocytes reportedly infected by PCV1- like particles were visual-
ized	by	electron	microscope	and	PCV1	DNA	was	detected	in	cells;	
however, infectivity was not determined.103 In another study, pro-
ductive PCV1 infection in a subclone of the human hepatocellular 
carcinoma cell line (Huh- 7, subclone 10- 3) was observed.104	With	
regard to PCV2, experimental infection was observed in human 
Rd cells.102
Porcine	circovirus	DNA	has	been	detected	in	U.S.	human	stool	
samples and approximately 5.3% (13/247) were positive for PCV1 
or	PCV2	DNA.105 This finding is thought to reflect dietary consump-
tion of PCV2- containing pork products rather than infection.105,106 
Noninfectious PCV1 has been detected in commercial pepsin, com-
mercial pig vaccines, and in U.S. pork products.105,107,108	PCV1	DNA	
was detected in Madin- Darby bovine kidney (MDBK) cells, which 
are used to grow selected animal vaccine virus strains.109 Thirty- one 
of 88 cell lines of various origin (cattle, pig, monkey, hamster, rat, 
mouse, rabbit, cat, sheep, canine, human, equine, and insect) and 
one in ten trypsin samples used for cell culture were positive for 
PCV1	DNA.110	In	January	2010,	an	academic	research	team	discov-
ered	PCV1	DNA	in	the	oral	live-	attenuated	human	rotavirus	vaccine,	
Rotarix™ (GlaxoSmithKline [GSK] Vaccines).17 However, there was no 
immunological or clinical evidence of PCV1 infection in infants who 
had received Rotarix™ in clinical trials.111
In summary, PCVs have been widely prevalent in the global 
swine population for many decades. However, there is no conclu-
sive evidence of human infections with PCV1 or PCV2 despite being 
constantly exposed to PCV by various routes and even in high- risk 
groups such as swine veterinarians.112,113
3.3.4 | Negative pig sources
Breeding stock free of PCV1 and PCV2 has been derived by a com-
bination	 of	 screening	 for	 PCV2	 DNA,	 colostrum	 deprivation,	 and	
enhanced biosecurity in husbandry.112,114,115 Secondary exposure of 
PCV2 naïve pigs to environmental contamination of the facility is the 
greatest challenge when maintaining PCV2 free populations, and it 
can be very difficult to decontaminate existing facilities.
4  | DISCUSSION
In	 general,	 ssDNA	 viruses	 infecting	 humans	 and	 pigs	 are	 widely	
prevalent and have high mutation rates. However, this high preva-
lence may not hinder the use of pig xenografts, as a recent report 
highlights that islet cells of pigs do not carry common pig viruses 
including PCV2 and PPV1, even if other cells such as PBMCs carry 
them.116 Indeed, xenotransplantation of islet cells from pigs to 
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cynomolgus monkeys in preclinical trials and from pigs to human 
patients in clinical trials has been achieved without transmission 
of	any	pig	viruses	including	ssDNA	viruses	such	as	PPV,	PCV1,	and	
PCV2.117,118 However, it should be noted that the donor pigs used in 
these	studies,	Auckland	Island	pigs	of	mixed	European	genetic	herit-
age, were from a specific pathogen- free breeding unit and confirmed 
PCV1 and PCV2 negative.117,118
Although	 currently,	 there	 is	 no	 explicit	 evidence	 of	 human	 in-
fection	and	pathogenesis	associated	with	pig	ssDNA	viruses	of	the	
Anelloviridae, Parvoviridae and Circoviridae families, precautions to 
address these viruses in xenotransplantation may need to be con-
sidered including careful screening and monitoring. Derivation of 
ssDNA	 virus-	free	 stock	 is	 possible	 by	 a	 combination	 of	 rigorous	
screening of breeding stock and piglets, cesarean section to de-
liver piglets, and colostrum deprivation. Recommendations and 
guidelines for donor pig- related testing have been summarized by 
the	 International	 Xenotransplantation	 Association.119 Prevention 
of infection of the derived virus- free stock is a more difficult task 
which requires a high level of biosecurity in housing and manage-
ment practices.112,114	 All	 nonenveloped	 ssDNA	 viruses	 are	 hardy,	
survive in the environment for prolonged periods, and are resistant 
to commonly used disinfectants.120-123	Animal	handlers	should	wear	
barrier overalls, gloves, and masks to prevent transmission of these 
ubiquitous viruses from the field to virus- free stock. In addition to 
the pig housing facility, equipment, water, feed, and veterinary sup-
plies are potential sources of contamination and should be screened 
and decontaminated thoroughly.114,120
Currently,	 commercial	 kits	 for	 surveillance	of	 ssDNA	viruses	by	
serology and PCR are available only for PPV1 and PCV2. However, 
primer	 sequences	 for	 detecting	 other	 pig	 ssDNA	 viruses	 by	
TABLE  2 Primers	and	probes	for	quantitative	detection	of	genomes	of	common	ssDNA	viruses	of	pigs
Virus Primers Reference
TTSuV 1a TTSuV-	F	5′-	CGAATGGCTGAGTTTATGCC 38
Common primer for all TTSuVs and a specific probe for 
each species
TTSuV 1b TTSuV-	R	5′-	GATAGGCCCCTTGACTCCG
TTSuV k2a TTSuV1-	Probe-	5′-	AACTGTCTAGCGACTGGGCGGGT-	3′
TTSuV k2b TTSuV2-	Probe	5′-	AACAGAGCTGAGTGTCTAACCGCCTG-	3′
PPV1 PPV1	F	5′-	CAGAATCAGCAACCTCACCA-	3′
PPV1	R	5′-	GCTGCTGGTGTGTATGGAAG-	3′
PPV1-	Probe	5′-	TGCAAGCTTAATGGTCGCACTAGACA-	3′
130
PPV2 PPV2-	DF	5′-	TACTGAGCCCTAAGACTGACTACAAGC-	3′
PPV2-	DR	5′-	GTTTGTCTCGTTGTTCGTCTGATG-	3′
PPV2-	Prob5′-	AACTGCTACATGAACCA	CTTTACCCCSTC-	3′
131
PPV3 PPV3F	5′-	CAYGAYGAACGGTACGATGAAAT-	3′
PPV3R-	5′-	GCGGTAAAACCTGTGAWAWTTGAAC-	3′
PPV3	Probe	5′-	TAGGTTGATGAATAAGGAGATAGAGAGGGCGG-	3′
132
PPV4 PPV4&5	F	5′-	GCATTGGTGTGTGTCTGTGTCC	-	3′
PPV4&5	R	5′-	GTGGCACATTTGTACATGGGAG-	3′
133
Common primers for PPV4 and PPV5 and a specific 
probe for each speciesPPV5 PPV4	probe	5′-	CTCCGCGGGATGTGCTTACAATTTTCA	-	3′
PPV5	probe	5′-	ACTTTGGTGTTGAGGGACTTAGCTTTTTTGTAC	-	3′
PPV6 PPV6F5′-	GGCTTCATAATCCCTCCAAAACCT-	3′
PPV6R5′-	GCTCATCTTCCTCTTGTTTCTCCTG-	3′
PPV6probe	5′-	CCTCCTCCTCCTCCCTCTCCAATTCCT-	3′
73
PBoV G1 G1F5′-	TGAGCTAATCCCTGAACTG	-	3′ 134
Primers	for	use	in	quantitative	real-	time	PCR	with	DNA	
intercalating fluorescent dyes such as SYBR Green or 
EVA	Green
G1R5′-	GTCTGAGCCTGTATCACCTAT-	3′
PBoV G2 G2F5′-	GGGCACTGATTATATCTTTAC-	3′
G2R5′-	CCCTGACATCTTTCCATT-	3′
PBoV G3 G3F5′-	ACTCTTTGCAGTCTGACTCT′TC-	3′
G3R-	5′-	GTTCCCCCGTGTCTTTAG-	3′
PCV1 PCV1	F	5′-	TGG	CCC	GCA	GTA	TTT	TGA	TT	-	3′
PCV1	R5′-	CAG	CTG	GGA	CAG	CAG	TTG	AG	-	3′
PCV1	Probe5′-	CAG	CAA	TCA	GGC	CCC	CCA	GGA	AT	-	3′
135
PCV2 PCV2	F-	5′-	CAG	CTG	GGA	CAG	CAG	TTG	AG	-	3′
PCV2	R-	5′-	TGG	CCC	GCA	GTA	TTT	TGA	TT	-	3′
Probe	5′-	CCA	GCA	ATC	AGA	CCC	CGT	TGG	AAT	G	-	3′
136
PCV3 PCV3	F-	5′-	AGT	GCT	CCC	CAT	TGA	ACG-	3′
PCV3	5′-	ACA	CAG	CCG	TTA	CTT	CAC-	3′
PCV3	probe	5′-	ACC	CCA	TGG	CTC	AAC	ACA	TAT	GAC	C–3′
93
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quantitative PCR are widely available in the literature (Table 2). In ad-
dition, primer- free metagenomic sequencing, which is getting more 
affordable by the day, is a powerful technique to screen for the above 
viruses.	Due	to	lack	of	in-	depth	knowledge	on	many	aspects	of	ssDNA	
viruses, it may be beneficial to screen for them at various levels, such 
as in the source herd, in donor pigs, harvested organs or cells, and in 
the donor recipients.124 It may also be beneficial to build dedicated 
facilities to rear such pigs. However, building and maintaining high- 
level biosecurity pig units is usually associated with a high cost, and 
with the current state of knowledge perhaps not justifiable. This will 
need to be further discussed with regulatory agencies. The majority of 
the	ssDNA	viruses	infecting	pigs	have	not	yet	been	cultured	in	vitro.	
Therefore, the development of pig and human cell line repositories, 
perhaps genetically engineered to remove innate antiviral defenses, 
would help in understanding the biology and risk posed by these vi-
ruses	in	xenotransplantation.	As	ssDNA	viruses	are	ubiquitous	in	pigs,	
they could be used as “indicators” to assess the level of “viral load” of 
the pigs intended for xenotransplantation to humans.125
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